- Retraction Note
- Open access
- Published:
Retraction Note: The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway
Journal of Experimental & Clinical Cancer Research volume 44, Article number: 71 (2025)
The Original Article was published on 04 October 2017
Retraction Note: J Exp Clin Cancer Res 36, 137 (2017)
https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13046-017-0607-0
The Editor-in-Chief has retracted this article. Several image integrity concerns were brought to the attention of the publisher after publication, including:
-
In figure 2B, FASC scatter plots appear to contain duplications between the GOLPH3L sh#1 SKOV3, GOLPH3L sh#2 SKOV3 and GOLPH3L sh#2 A2780 plots
-
In figure 3F, the top of image A2780 vector-Active Caspase 3 appears to contain overlap with the bottom of A2780 GOLPH3L- Active Caspase 3
-
In figure 4E, there appear to be high similarities between panel α-Tubulin - SKOV3 - control/GOLPH3L-2h#1- control/GOLPH3L-2h#2 and figure 5A α-Tubulin in another article published earlier by different authors [1].
The authors were not able to provide a satisfactory explanation for these concerns and described repeated issues with data labelling and storage practices. Therefore the Editor has lost confidence in the data and conclusions of this article.
Author Shengyang He disagrees with this retraction. All other authors have not responded to correspondence regarding this retraction.
Reference
Lei Shang-tong, et al. MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression. Biomed Pharmacother. 2016;84:1834–40.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
He, S., Niu, G., Shang, J. et al. Retraction Note: The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway. J Exp Clin Cancer Res 44, 71 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13046-025-03344-4
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13046-025-03344-4